SCHEMBL2652827

SCHEMBL2652827

CS(=O)(=O)c1ccc(C2(C(=O)O)CC2)c(C2CCCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.42
▸ SLC6A9 P48067 1/20 0.39
▸ CNR2 P34972 2/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ HRH4 Q9H3N8 3/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ CLK1 P49759 1/20 0.35
▸ TBXA2R P21731 1/20 0.35
▸ PTGDR Q13258 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2653280 0.99 PTGS2 (0.44) PTGS2SLC6A9CNR2KMT2AHRH4
SCHEMBL2654132 0.85 PTGS2 (0.41) PTGS2SLC6A9KMT2AHRH4MEN1
SCHEMBL2652798 0.85 ALDH1A1 (0.42) PTGS2KMT2ACYP3A4MEN1SLC6A2
SCHEMBL2652919 0.83 CNR2 (0.36) CNR2KMT2ACYP3A4LMNAALDH1A1
SCHEMBL2653267 0.81 CA2 (0.38) CNR2CYP3A4
SCHEMBL2652954 0.79 PTGS2 (0.45) PTGS2SLC6A9KMT2AHRH4KDM1A
SCHEMBL2652996 0.78 PTGS2 (0.47) PTGS2SLC6A9KMT2AHRH4KDM1A
SCHEMBL2653194 0.78 CYP3A4 (0.39) CYP3A4PTGDR
SCHEMBL2652918 0.78 KMT2A (0.43) PTGS2CNR2KMT2AKDM1ACYP3A4
SCHEMBL2653490 0.77 CYP3A4 (0.41) KMT2ACYP3A4MEN1PTGDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585739-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2005-10-19 — — EP disclosed
WO-2004063179-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2004-07-29 — — WO disclosed
Send feedback